Refractory dermatomyositis responsive to anifrolumab

Saved in:
Bibliographic Details
Published in:JAAD Case Reports 2024-01, Vol.43, p.27-29
Main Authors: Ang, Phillip S., Ezenwa, Ekene, Ko, Kichul, Hoffman, Mark D.
Format: Article
Language:English
Subjects:
anifrolumab
antibody
biologic
dermatomyositis
interferon
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3
cites cdi_FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3
container_end_page 29
container_issue
container_start_page 27
container_title JAAD Case Reports
container_volume 43
creator Ang, Phillip S.
Ezenwa, Ekene
Ko, Kichul
Hoffman, Mark D.
description
doi_str_mv 10.1016/j.jdcr.2023.10.023
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0c6ef2650cee41ddaa0d31f66ef3e069</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352512623004137</els_id><doaj_id>oai_doaj_org_article_0c6ef2650cee41ddaa0d31f66ef3e069</doaj_id><sourcerecordid>38162409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3</originalsourceid><addsrcrecordid>eNp9kMtKAzEYhYMottS-gAuZF5gx93bAjRQvhYIgug6Z5I9k6DQlGQt9ezOOFleuTjj85yN8CF0TXBFM5G1btdbEimLKclHlOENTygQtBaHy_M97guYptRhjIviCLcglmrAlkZTjeor4K7ioTR_isbAQO92H7hiS730qIqR92CV_gKIPhd55F8P2s9PNFbpweptg_pMz9P748LZ6LjcvT-vV_aY0jC9ZSaEWcqkZBm6k0ZRaoMQZrpuaYwFUmkXjMNDaEUbBCNLIWjSCOUJqCVyzGVqPXBt0q_bRdzoeVdBefRchfigde2-2oLCR4KgU2ABwYq3W2DLiZG4ZYFlnFh1ZJoaUIrgTj2A1GFWtGoyqwejQ5cijm3G0_2w6sKfJr798cDceQNZw8BBVMh52BqyPYPr8T_8f_wvwroc9</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Refractory dermatomyositis responsive to anifrolumab</title><source>PubMed (Medline)</source><source>ScienceDirect Journals</source><creator>Ang, Phillip S. ; Ezenwa, Ekene ; Ko, Kichul ; Hoffman, Mark D.</creator><creatorcontrib>Ang, Phillip S. ; Ezenwa, Ekene ; Ko, Kichul ; Hoffman, Mark D.</creatorcontrib><identifier>ISSN: 2352-5126</identifier><identifier>EISSN: 2352-5126</identifier><identifier>DOI: 10.1016/j.jdcr.2023.10.023</identifier><identifier>PMID: 38162409</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>anifrolumab ; antibody ; biologic ; dermatomyositis ; interferon</subject><ispartof>JAAD Case Reports, 2024-01, Vol.43, p.27-29</ispartof><rights>2023 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3</citedby><cites>FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2352512623004137$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38162409$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ang, Phillip S.</creatorcontrib><creatorcontrib>Ezenwa, Ekene</creatorcontrib><creatorcontrib>Ko, Kichul</creatorcontrib><creatorcontrib>Hoffman, Mark D.</creatorcontrib><title>Refractory dermatomyositis responsive to anifrolumab</title><title>JAAD Case Reports</title><addtitle>JAAD Case Rep</addtitle><subject>anifrolumab</subject><subject>antibody</subject><subject>biologic</subject><subject>dermatomyositis</subject><subject>interferon</subject><issn>2352-5126</issn><issn>2352-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kMtKAzEYhYMottS-gAuZF5gx93bAjRQvhYIgug6Z5I9k6DQlGQt9ezOOFleuTjj85yN8CF0TXBFM5G1btdbEimLKclHlOENTygQtBaHy_M97guYptRhjIviCLcglmrAlkZTjeor4K7ioTR_isbAQO92H7hiS730qIqR92CV_gKIPhd55F8P2s9PNFbpweptg_pMz9P748LZ6LjcvT-vV_aY0jC9ZSaEWcqkZBm6k0ZRaoMQZrpuaYwFUmkXjMNDaEUbBCNLIWjSCOUJqCVyzGVqPXBt0q_bRdzoeVdBefRchfigde2-2oLCR4KgU2ABwYq3W2DLiZG4ZYFlnFh1ZJoaUIrgTj2A1GFWtGoyqwejQ5cijm3G0_2w6sKfJr798cDceQNZw8BBVMh52BqyPYPr8T_8f_wvwroc9</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Ang, Phillip S.</creator><creator>Ezenwa, Ekene</creator><creator>Ko, Kichul</creator><creator>Hoffman, Mark D.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202401</creationdate><title>Refractory dermatomyositis responsive to anifrolumab</title><author>Ang, Phillip S. ; Ezenwa, Ekene ; Ko, Kichul ; Hoffman, Mark D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anifrolumab</topic><topic>antibody</topic><topic>biologic</topic><topic>dermatomyositis</topic><topic>interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ang, Phillip S.</creatorcontrib><creatorcontrib>Ezenwa, Ekene</creatorcontrib><creatorcontrib>Ko, Kichul</creatorcontrib><creatorcontrib>Hoffman, Mark D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JAAD Case Reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ang, Phillip S.</au><au>Ezenwa, Ekene</au><au>Ko, Kichul</au><au>Hoffman, Mark D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Refractory dermatomyositis responsive to anifrolumab</atitle><jtitle>JAAD Case Reports</jtitle><addtitle>JAAD Case Rep</addtitle><date>2024-01</date><risdate>2024</risdate><volume>43</volume><spage>27</spage><epage>29</epage><pages>27-29</pages><issn>2352-5126</issn><eissn>2352-5126</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38162409</pmid><doi>10.1016/j.jdcr.2023.10.023</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2352-5126
ispartof JAAD Case Reports, 2024-01, Vol.43, p.27-29
issn 2352-5126
2352-5126
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0c6ef2650cee41ddaa0d31f66ef3e069
source PubMed (Medline); ScienceDirect Journals
subjects anifrolumab
antibody
biologic
dermatomyositis
interferon
title Refractory dermatomyositis responsive to anifrolumab
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A27%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Refractory%20dermatomyositis%20responsive%20to%20anifrolumab&rft.jtitle=JAAD%20Case%20Reports&rft.au=Ang,%20Phillip%20S.&rft.date=2024-01&rft.volume=43&rft.spage=27&rft.epage=29&rft.pages=27-29&rft.issn=2352-5126&rft.eissn=2352-5126&rft_id=info:doi/10.1016/j.jdcr.2023.10.023&rft_dat=%3Cpubmed_doaj_%3E38162409%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3483-2e9568a30e4c6ca22de21fc4ab9405e26c7bf0e29f132ec51b695b53f1196e4a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/38162409&rfr_iscdi=true